Capital Flow Monitor · Sponsors · CIK 1455364
SYNDEVRX INC
ONE BROADWAY, CAMBRIDGE, MA, 02142 · 617-401-3110
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$20.0M
Sold
$6.5M
% sold
32.3%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | D/A ·current | 506(b) | $20.0M | $6.5M | 32.3% | 7 | EDGAR ↗ |
| 2025-11-17 | D/A | 506(b) | $12.0M | $6.5M | 53.9% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Bradley J Carver — Executive Officer / Director, Cambridge, MA
- James Michael Shanahan — Executive Officer / Director, Cambridge, MA
- Charles Flynn — Director, Cambridge, MA
- Jeffrey Welles — Director, Cambridge, MA
- Michael Clifford — Director, Cambridge, MA
-
David Neafus — Executive Officer, Cambridge, MA
1 other raise
- SightStream Biotherapeutics, Inc. $1.8M of $1.8M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.